Use of treatment pathway improves neoadjuvant chemotherapy use in muscle-invasive bladder cancer

ConclusionsIn this review of 20 years of experience, we report a dramatic rise in the use of NAC after adoption of a multidisciplinary pathway that is associated with expected survival benefits.

http://link.springer.com/10.1007/s11255-020-02752-z

Source: International Urology and Nephrology - January 3, 2021 Category: Urology & Nephrology Source Type: research